A Avantor, Inc.
| Market Cap | $5.39B |
| P/E Ratio | — |
| Forward P/E | 9.28 |
| Dividend Yield | — |
| Beta | 1.00 |
| 52W Range | $7.41 - $15.89 |
| # Hedge Funds | 5 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Hedge Fund Ownership
| Investor 5 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Greenhaven Associates Greenhaven Associates | 3.81% | $234.94M | 20,500,653 | Add 11.95% |
| Robert Olstein Olstein Capital Management | 2.07% | $9.00K | 818,000 | Add 3.02% |
| Mason Hawkins Southeastern Asset Management | 1.81% | $40.66M | 3,548,518 | Reduce 31.09% |
| Dodge & Cox Dodge & Cox | 0.72% | $1.34B | 117,065,143 | Reduce 0.58% |
| Steven Romick First Pacific Advisors | 0.60% | $45.48M | 3,968,620 | Reduce 2.51% |
Insider Trading
| Insider Name of the company insider who made the trade 7 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| MEHRA SANJEEV K | Buy | 125,000 | $8.01 | $1.00M | 10 Mar 2026 | 10 Mar 2026 |
| LUCIER GREGORY T | Buy | 50,000 | $9.16 | $458.00K | 19 Feb 2026 | 23 Feb 2026 |
| SUMME GREGORY L | Buy | 100,000 | $9.40 | $940.00K | 12 Feb 2026 | 12 Feb 2026 |
| MEHRA SANJEEV K | Buy | 350,000 | $11.09 | $3.88M | 05 Dec 2025 | 09 Dec 2025 |
| Ligner EmmanuelPresident and CEO | Buy | 87,500 | $11.35 | $993.13K | 17 Nov 2025 | 17 Nov 2025 |
| SUMME GREGORY L | Buy | 100,000 | $11.25 | $1.13M | 30 Oct 2025 | 31 Oct 2025 |
| Gregory L SummeDirector | Buy | 100,000 | $11.25 | $1.13M | 30 Oct 2025 | 31 Oct 2025 |
Frequently Asked Questions
What is AVTR stock price today?
Avantor, Inc. (AVTR) is currently trading at $7.90. The stock has a 52-week range of $7.41 to $15.89 and a market capitalization of $5.39B.
Is AVTR a good stock to buy in 2026?
Avantor, Inc. has a P/E ratio of N/A (forward P/E: 9.3), a dividend yield of none, and 1-year performance of -49.6%. 5 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling AVTR stock?
There have been 7 insider transactions for AVTR in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has AVTR stock performed over the past year?
Avantor, Inc. (AVTR) has returned -49.6% over the past 12 months. The stock traded between $7.41 and $15.89 during this period, and is currently at $7.90.
Which hedge funds own AVTR (Avantor, Inc.)?
5 tracked hedge funds currently hold AVTR in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is AVTR's market cap and valuation?
Avantor, Inc. (AVTR) has a market capitalization of $5.39B. The trailing P/E ratio is N/A and forward P/E is 9.3. The stock is classified in the Healthcare sector.
What is AVTR's revenue and profitability?
Avantor, Inc. reported revenue of $6.55B with net income of N/A and a profit margin of N/A. The stock has a beta of 1.00.
What sector is AVTR in and who are its biggest institutional holders?
Avantor, Inc. (AVTR) operates in the Healthcare sector. It is held by 5 tracked hedge funds. See the ownership table above for the complete list.